Goldline Pharmac

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1CLW01015
  • NSEID:
  • BSEID: 544759
INR
43.15
-1.05 (-2.38%)
BSENSE

Jun 09, 03:30 PM

BSE+NSE Vol: 117000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10040007,
    "name": "Goldline Pharmac",
    "stock_name": "Goldline Pharmac",
    "full_name": "Goldline Pharmaceutical Ltd",
    "name_url": "stocks-analysis/goldline-pharmac",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "43.15",
    "chg": -1.05,
    "chgp": "-2.38%",
    "dir": -1,
    "prev_price": "44.20",
    "mcapval": "42.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544759,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE1CLW01015",
    "curr_date": "Jun 09, 03:30 PM",
    "curr_time": "04:59 AM",
    "last_traded_at": "Jun 09, 03:30 PM IST",
    "bse_nse_vol": 117000,
    "exc_status": "Active",
    "traded_date": "Jun 09, 2026",
    "traded_date_str": "2026 06 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/goldline-pharmac-10040007-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10040007",
    "stock_news_url": "https://www.marketsmojo.com/news/goldline-pharmaceutical-10040007"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 To Be Held On Tuesday June 09 2026.",
      "datetime": "02-Jun-2026",
      "details": "Goldline Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2026 inter alia to consider and approve Standalone Audited financials results for the half year and year ended 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Listing of Equity Shares of Goldline Pharmaceutical Ltd",
      "datetime": "19-May-2026",
      "details": "Trading Members of the Exchange are hereby informed that effective from May 19 2026 the Equity Shares of Goldline Pharmaceutical Ltd (Scrip Code: 544759) are listed and admitted to dealings on the Exchange in the list of MT Group Securities. For further details please refer to the notice no. 20260518- dated May 18 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 To Be Held On Tuesday June 09 2026.

02-Jun-2026 | Source : BSE

Goldline Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2026 inter alia to consider and approve Standalone Audited financials results for the half year and year ended 31st March 2026.

Listing of Equity Shares of Goldline Pharmaceutical Ltd

19-May-2026 | Source : BSE

Trading Members of the Exchange are hereby informed that effective from May 19 2026 the Equity Shares of Goldline Pharmaceutical Ltd (Scrip Code: 544759) are listed and admitted to dealings on the Exchange in the list of MT Group Securities. For further details please refer to the notice no. 20260518- dated May 18 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available